Measuring the plasma eMTBR-tau243 biomarker may serve as a practical, less invasive method of capturing Alzheimer's disease-specific pathological changes and may play an important role in etalanetug's ...
Fitgurú on MSN
Could a Simple Blood Test Predict Alzheimers Years Before Symptoms? New Research Offers Hope
Scientists are making significant progress in the early detection of Alzheimer's disease. New findings suggest that a ...
Primary care docs in Sweden diagnosed Alzheimer's with the same accuracy as dementia specialists when they had access to beta ...
Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers due to its aggressive biology and ...
Spectris increased CSF levels of multiple HDL-like lipid transport proteins, suggesting a “coordinated biological response” ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), today highlighted the recent update to the National Comprehensive Cancer Network (NCCN) Clinical ...
PMN310 demonstrated dose-dependent reduction of amyloid-beta oligomers in human cerebrospinal fluid following a single dose in healthy volunteers Represents one of the first quantitative measures of ...
ProMIS Neurosciences Inc. , a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced the ...
Cognito Therapeutics, a clinical-stage neurotechnology company developing novel therapies for neurodegenerative disorders, ...
Eisai Co., Ltd. today announced the latest findings on etalanetug (development code: E2814) showed that this investigational ...
D-PAULM, a noninvasive imaging technique, tracked the brain’s glymphatic system and blood flow in real time, potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results